SNNUFNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesUS GAAP · USD

Smith & Nephew SNATS, Inc

Smith & Nephew plc is a UK-founded medical technology company that develops and sells orthopedic, sports medicine, ENT, and advanced wound care products. Its business serves hospitals, surgeons, clinicians, and other healthcare providers through a global network spanning about 100 countries.

Liiketoiminta

Osuus liikevaihdosta
Orthopaedics45 %

Joint reconstruction, trauma, and related orthopedic implants and systems.

Sports Medicine & ENT30 %

Arthroscopic, sports injury, and ear, nose, and throat surgical devices.

Advanced Wound Management25 %

Dressings, wound closure, and therapies for complex wound care.

Asiakkaat

Smith & Nephew sells primarily to healthcare providers that use its products in surgery, wound treatment, and hospital care. Demand comes from clinicians and purchasing organizations that specify products for orthopedic procedures, sports injury repair, ENT procedures, and chronic or acute wound management. The business is shaped by procedure volumes, hospital purchasing cycles, and clinical preference for its branded technologies.

Hospitals and health systems

Buy implants, surgical devices, and wound products for inpatient and outpatient procedures.

Orthopedic surgeons

Use joint reconstruction, trauma, and related systems in orthopedic procedures.

Sports medicine and ENT surgeons

Buy arthroscopy, soft-tissue repair, and ENT instruments for procedural use.

Wound care providers

Purchase dressings and therapies for chronic, surgical, and hard-to-heal wounds.

Public procurement organizations

Tender and contract buyers that influence pricing, product access, and volume.

Strategia

The company’s strategy centers on improving its portfolio through product innovation in Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. Its global scale and clinical breadth are important because they support surgeon adoption, hospital relationships, and cross-selling across procedure types.

Product innovationKeskipitkä aikaväli

Clinical performance and new technology adoption are central to share gains in medtech.

Global commercial executionLyhyt aikaväli

A broad geographic footprint helps diversify demand and access large procedure markets.

Portfolio breadthKeskipitkä aikaväli

Multiple adjacent categories reduce dependence on any single procedure area.

Maantiede

Smith & Nephew operates globally and reports business across around 100 countries, with a major international footprint centered in Europe, North America, and other overseas markets. Its UK roots and global distribution base mean revenue is tied to healthcare spending patterns, tender systems, and procedure volumes across multiple regions.

Riskit

Smith & Nephew faces typical medtech risks from regulation, product quality, and reimbursement pressure, because its products are used in invasive procedures and sold into regulated healthcare systems. Its global footprint also creates foreign exchange exposure, geopolitical and supply-chain sensitivity, and dependence on hospital capital and procurement budgets.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Healthcare purchasing cycles1Regulatory and clinical compliance2Foreign exchange volatility3Supply chain and geopolitical disruption4
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Healthcare purchasing cyclesVaikutus: KorkeaTodennäköisyys: Korkea

    Hospital budgets, tenders, and procedure volumes can shift demand and timing of purchases.

    Kohdistuu: Hospital and public sector customers

  2. Regulatory and clinical complianceVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Medical devices require approvals, quality controls, and ongoing compliance in many jurisdictions.

    Kohdistuu: Orthopaedics and surgical devices

  3. Foreign exchange volatilityVaikutus: KeskitasoTodennäköisyys: Korkea

    Sales and costs span many currencies, so translation and transaction effects can move reported results.

    Kohdistuu: Global operations

  4. Supply chain and geopolitical disruptionVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    A global manufacturing and distribution model is exposed to logistics, trade, and regional disruptions.

    Kohdistuu: Around 100-country footprint

Kirjanpito

Harkinnanvaraiset erät
Constant currency revenue

Management uses underlying revenue growth adjusted for currency translation, which can differ from reported growth.

Vaikutus: Affects comparability of period-to-period sales trends

Foreign exchange translation

Multi-currency operations create translation effects on revenue, expenses, and net assets.

Vaikutus: Can materially change reported performance

Goodwill and intangible impairment

Acquisitions and branded product portfolios require ongoing impairment assessment.

Vaikutus: May create non-cash charges if expectations weaken

Provisions and product quality claims

Medical device businesses may record warranty, recall, or legal provisions.

Vaikutus: Can affect operating expense and liabilities

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 28.9.2026

Smith & Nephew SNATS, Inc (NYSE) – Orthopedic, Prosthetic & Surgical Applia | Analyysi – Clarifo